- The increase in turnover of the Bettlach
Orthopaedic Company Mathys lies at 10.1%, well ahead of the business
sector average. 2007 stands out as the year in which Mathys entered
the Asian market as well as the year in which new innovative products
The family business once again records a growth in turnover,
considerably higher than the market average. With consolidated sales
of CHF 81.7 Mio. this growth represents an increase of 10.1% compared
The number of staff remains practically unchanged with 391 staff
employed worldwide, 218 of whom are located in Switzerland. Due to
the competitive labour market situation and the high level of
employment, Mathys currently has 13 positions vacant.
The major sales area remains that of hip joint replacement. The
largest growth areas are in the fields of knee and shoulder joint
replacement. The development of the business unit Bio-surgery for
bone replacement continues and contributes substantially to the
achievement of the sales target.
Continued Market Expansion
In 2007 Mathys entered new markets in South America and Asia.
Mathys products are now available through agents and distributors in
important Asiatic markets such as Singapore, Malaysia, Indonesia and
India. The entry into China is being prepared. Alongside its 9
subsidiaries, Mathys also works with 30 distributors and agents
The good results in 2007 were also supported by the introduction
of new innovative products. In the hip group, all major product
ranges were complemented in 2007 by the addition of minimal invasive
operation techniques, through which the tissue is protected. A new
knee system was introduced, giving the patient extremely high
mobility after the operation. This enables operations to be performed
on younger patients who are pursuing active sport. An innovative
inverse prosthesis was added to the shoulder product group. In
addition to the above Mathys also launched the world's first fully
synthetic kneadable bone replacement material in the summer. The
so-called "Putty" is used to fill missing bone mass and in doing so
enables bone remodelling within a few months. Thanks to its
malleability and the simple application method, the operation time
can be shortened. The patients' recovery period is also reduced.
Continued Company Development in 2008
The planned sales growth will be achieved through further
investment in growth areas and the launch of innovative products.
Following on from the achievements in 2007, Mathys can expect 2008 to
be a further above average successful year. The optimisation of the
production process is a focal point, as are higher revenue and
careful control of the working capital. The head count will remain
stable, despite the challenges presented by the current market
situation in filling vacancies.
General Information about Mathys Ltd Bettlach
Focused entirely on the joint replacement business since 1
November 2003, Mathys produces hip, knee and shoulder implants, plus
a range of biomaterials, in Bettlach and in Germany.
Mathys has developed, produced and distributed joint replacement
products since 1963, but only started selling own brand implants in
1996/97. The company, which has nine subsidiaries in Germany, France,
Belgium, England, Holland, Austria, Australia, New Zealand and
Switzerland, is owned by the Mathys and Marzo families. Hugo Mathys
is Chairman of the Board of Directors and CEO; Dr. Arne Faisst is COO
and is Chairman of the Executive Board.
ots Originaltext: Mathys Ltd Bettlach
Head Corporate and Market Communication
Mathys Ltd Bettlach
2544 Bettlach, Switzerland
Telephone direct: +41/32/644'14'97
Fax direct: +41/32/644'14'60